Jochem H Bernink Selected Research

CCR10 Receptors

1/2019

c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jochem H Bernink Research Topics

Disease

4	Inflammation (Inflammations) 01/2018 - 08/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2019 - 09/2014
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2018 - 07/2014
1	Infections 01/2021
1	Bacterial Pneumonia 01/2021
1	Pneumonia (Pneumonitis) 01/2021
1	Bacterial Infections (Bacterial Infection) 01/2018
1	Wounds and Injuries (Trauma) 01/2018
1	Nasal Polyps (Nasal Polyp) 01/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2016
1	Rhinosinusitis 01/2016
1	Leukemia 07/2014
1	Mucositis 07/2014
1	Colonic Neoplasms (Colon Cancer) 08/2013
1	Neoplasms (Cancer) 08/2013

Drug/Important Bio-Agent (IBA)

3	CytokinesIBA 01/2018 - 08/2013
2	Interleukin-22 (IL-22)IBA 01/2018 - 09/2014
2	Phosphotransferases (Kinase)IBA 01/2018 - 08/2013
1	Interleukin-33IBA 01/2021
1	CCR10 ReceptorsIBA 01/2019
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Interleukin-12 (IL 12)IBA 01/2016
1	Interleukin-4 (Interleukin 4)IBA 01/2016
1	Interleukin-23 (Interleukin 23)IBA 09/2014
1	tyrosine receptor (receptor, tyrosine)IBA 08/2013
1	AzoxymethaneIBA 08/2013
1	Dextran SulfateIBA 08/2013

Therapy/Procedure

3	Therapeutics 01/2018 - 08/2013
2	Hematopoietic Stem Cell Transplantation 01/2018 - 07/2014
1	Induction Chemotherapy 07/2014
1	Chemoradiotherapy 07/2014